Cannabidiol + delta 9 tetrahydrocannabinol

Unassigned

New Medicines

Uncontrolled pain related to advanced incurable cancer

Information

New formulation
Tetra Bio-Pharma
Tetra Bio-Pharma

Development and Regulatory status

None
None
Phase III Clinical Trials

Category

Cannabinoid receptor agonist presented in a CAUMZ™ Kit which comprises of capsules coated with 17mg delta-9-tetrahydrocannibinol and 5mg cannabidiol with a handheld Mighty Medic vaporiser
Between 30 to 60% of patients with cancer have some sort of pain. With advanced cancer, pain is more likely and up to 90% have pain. One in two people in the UK will get cancer in their lifetime.[1]
Uncontrolled pain related to advanced incurable cancer
Inhalation